Eledon Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ELDN) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 11.77 M18.99 M16.06 M17.71 M14.48 M 67.24 M Cash from investing activities 12.8 M47.38 M3.89 M14.96 M12.4 M 78.64 M Cash from financing activities 5.28 M80.17 M115 K00 80.28 M Free cash flow 11.77 M18.99 M16.06 M17.71 M14.48 M 67.24 M

Notícias

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon apresenta dados positivos de 24 meses de transplante renal para tegoprubart

Eledon reports positive 24-month kidney transplant data for tegoprubart

Tegoprubart da Eledon mostra resultados promissores em transplantes renais

Eledon’s tegoprubart shows promise in kidney transplantation trials

Ações da Eledon Pharmaceuticals sobem após dados positivos de transplante de ilhotas

Eledon Pharmaceuticals stock rises after positive islet transplant data

Anticorpo anti-CD40L da Eledon mostra resultados promissores em ensaio de diabetes

Eledon’s anti-CD40L antibody shows promise in diabetes trial

Guggenheim reduz preço-alvo das ações da Eledon Pharmaceuticals devido à diluição

Guggenheim lowers Eledon Pharmaceuticals stock price target on dilution

Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript